ResearchMoz.us include new market research report " China Vitamin Industry Report,2014-2017: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.
China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.
Browse Full Report with TOC at: http://www.researchmoz.us/china-vitamin-industry-report2014-2017-report.html
China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.
Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.
In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.
Browse More Reports related to Pharmaceuticals at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.
Related Reports:-
Currently, Japanese manufacturers dominate the supply of the global aluminum electrolytic capacitors, four of which rank among top five players worldwide, namely Chemi-con, Nichicon, Rubycon and Panasonic, totally enjoyed 64% of the global share in 2013, and followed by Taiwan-based companies with 14%. In 2013, Mainland China produced about 109.5 billion aluminum electrolytic capacitors, up 9.5% year on year; it gained the sales revenue of RMB10.4 billion, representing a year-on-year increase of 9.47%. As the global aluminum electrolytic capacitor manufacturing is shifting to Mainland China, Japan, South Korea, Taiwan and Hong Kong manufacturers have set up their plants in Mainland China in recent years.
About Us:
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Mrs.Sheela AK
Tel:+1-518-618-1030
Toll Free: 866-997-4948
Email: sales@researchmoz.us
0 comments:
Post a Comment